piracetam has been researched along with Brain Diseases in 22 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "ACTH and levetiracetam had good therapeutic effects in epilepsy control in this case of de novo STXBP1 mutation." | 4.98 | Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review. ( Cai, XT; Liu, S; Wang, L; Wang, Z; Yu, D; Zhou, H, 2018) |
| "Extensive research of the recent years has demonstrated that piracetam is effective in the treatment of cognitive decline in aging and dementia." | 4.80 | Piracetam: novelty in a unique mode of action. ( Eckert, A; Eckert, GP; Müller, WE, 1999) |
| "We report the case of an aborted awake craniotomy for a left frontotemporoinsular glioma due to ammonia encephalopathy on a patient taking Levetiracetam, valproic acid and clobazam." | 3.81 | Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy. ( Arroyo Pérez, R; Fernández-Candil, JL; León Jorba, A; Pacreu Terradas, S; Villalba Martínez, G; Vivanco-Hidalgo, RM, 2015) |
| "Piracetam has a cerebroprotective effect in patients undergoing coronary artery bypass surgery with the use of cardiopulmonary bypass." | 2.73 | Cerebroprotective effect of piracetam in patients undergoing coronary bypass burgery. ( Alaaraj, N; Claus, B; Dohmen, PM; Holinski, S; Kirilova, K; Konertz, W; Neumann, K; Uebelhack, R, 2008) |
| "STXBP1-related encephalopathy is a brain dysfunction caused by STXBP1 variation." | 1.72 | Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra. ( Cao, JJ; Chen, HM; Chen, Q; He, W; Liu, LY; Lu, Q; Luo, XM; Shen, YW; Wang, J; Wang, QH; Wang, YY; Zhang, MN; Zou, LP, 2022) |
| "Older patients and patients with brain tumors or strokes were preferentially treated with LEV for prevention and/or management of seizures (all P < or = 0." | 1.34 | Levetiracetam use in critically ill patients. ( Meckler, JM; Privitera, MD; Shutter, LA; Szaflarski, JP; Szaflarski, M; Yates, SL, 2007) |
| "The woman had cardiac arrest complicated by ischemic stroke involving the left parietal region." | 1.29 | [Myoclonus of focal action and localized hemispheric lesion. A polygraphic and pharmacological study]. ( Bartolomei, F; Bureau, M; Genton, P; Paglia, G; Roger, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, QH | 1 |
| Cao, JJ | 1 |
| Wang, YY | 1 |
| Zhang, MN | 1 |
| Liu, LY | 1 |
| Wang, J | 1 |
| Lu, Q | 1 |
| He, W | 1 |
| Shen, YW | 1 |
| Chen, HM | 1 |
| Luo, XM | 1 |
| Chen, Q | 1 |
| Zou, LP | 1 |
| Liu, S | 1 |
| Wang, L | 1 |
| Cai, XT | 1 |
| Zhou, H | 1 |
| Yu, D | 1 |
| Wang, Z | 1 |
| Tayah, T | 1 |
| Savard, M | 1 |
| Desbiens, R | 1 |
| Nguyen, DK | 1 |
| Villalba Martínez, G | 1 |
| Fernández-Candil, JL | 1 |
| Vivanco-Hidalgo, RM | 1 |
| Pacreu Terradas, S | 1 |
| León Jorba, A | 1 |
| Arroyo Pérez, R | 1 |
| Waheed, W | 1 |
| Nathan, MH | 1 |
| Allen, GB | 1 |
| Borden, NM | 1 |
| Babi, MA | 1 |
| Tandan, R | 1 |
| Pandey, S | 1 |
| Garabadu, D | 1 |
| Neznamov, GG | 2 |
| Teleshova, ES | 2 |
| Holinski, S | 1 |
| Claus, B | 1 |
| Alaaraj, N | 1 |
| Dohmen, PM | 1 |
| Kirilova, K | 1 |
| Neumann, K | 1 |
| Uebelhack, R | 1 |
| Konertz, W | 1 |
| Batysheva, TT | 1 |
| Otcheskaia, OV | 1 |
| Nesterova, ON | 1 |
| Lisinker, LN | 1 |
| Bobina, LA | 1 |
| Ismailov, AM | 1 |
| Shekkhirimov, RK | 1 |
| Zhuravleva, EIu | 1 |
| Kamchatnov, PR | 1 |
| Boĭko, AN | 1 |
| Aricò, I | 1 |
| Condurso, R | 1 |
| Granata, F | 1 |
| Nobili, L | 1 |
| Bruni, O | 1 |
| Silvestri, R | 1 |
| Artemowicz, B | 1 |
| Sobaniec, W | 1 |
| Donaire, A | 1 |
| Carreno, M | 1 |
| Gómez, B | 1 |
| Fossas, P | 1 |
| Bargalló, N | 1 |
| Agudo, R | 1 |
| Falip, M | 1 |
| Setoaín, X | 1 |
| Boget, T | 1 |
| Raspall, T | 1 |
| Obach, V | 1 |
| Rumiá, J | 1 |
| Berger, A | 1 |
| Schroeter, C | 1 |
| Wiemer-Kruel, A | 1 |
| Strobl, K | 1 |
| Hoffmann, GF | 1 |
| Rating, D | 1 |
| Lebon, P | 1 |
| Ernst, JP | 1 |
| Wolf, NI | 1 |
| Szaflarski, JP | 1 |
| Meckler, JM | 1 |
| Szaflarski, M | 1 |
| Shutter, LA | 1 |
| Privitera, MD | 1 |
| Yates, SL | 1 |
| Bauer, J | 1 |
| Waters, B | 1 |
| Resnick, M | 1 |
| Simeon, J | 1 |
| Trites, R | 1 |
| Fiedorowicz, C | 1 |
| Bartolomei, F | 1 |
| Bureau, M | 1 |
| Paglia, G | 1 |
| Genton, P | 1 |
| Roger, J | 1 |
| Müller, WE | 1 |
| Eckert, GP | 1 |
| Eckert, A | 1 |
| Godard, JP | 1 |
| Goerens, C | 1 |
| Grelier, C | 1 |
| Niss, AI | 1 |
| Trubkovich, MIa | 1 |
| Solberg, VR | 1 |
3 reviews available for piracetam and Brain Diseases
| Article | Year |
|---|---|
Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Brain Diseases; Electroencephalography; Epilepsy; Fema | 2018 |
Neuroprotection possibilities in epileptic children.
Topics: Anticonvulsants; Brain Diseases; Child; Epilepsy; Fructose; Humans; Levetiracetam; Neuroprotective A | 2005 |
Piracetam: novelty in a unique mode of action.
Topics: Aged; Aging; Animals; Blood Cells; Brain; Brain Diseases; Cell Membrane; Cerebrovascular Circulation | 1999 |
1 trial available for piracetam and Brain Diseases
| Article | Year |
|---|---|
Cerebroprotective effect of piracetam in patients undergoing coronary bypass burgery.
Topics: Brain Diseases; Coronary Artery Bypass; Humans; Middle Aged; Piracetam | 2008 |
18 other studies available for piracetam and Brain Diseases
| Article | Year |
|---|---|
Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra.
Topics: Anticonvulsants; Brain Diseases; Humans; Levetiracetam; Munc18 Proteins; Phenotype; Piracetam | 2022 |
Ictal bradycardia and asystole in an adult with a focal left insular lesion.
Topics: Anticonvulsants; Benzodiazepines; Bradycardia; Brain Diseases; Cerebral Cortex; Clobazam; Drug Resis | 2013 |
Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy.
Topics: Anesthesia, General; Anesthesia, Local; Anticonvulsants; Aphasia; Benzodiazepines; Brain Diseases; B | 2015 |
Neurofibromatosis 1-associated panhypopituitarism presenting as hypoglycaemic seizures and stroke-like symptoms.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Antiviral Agents; Brain Diseases; Cafe-au-Lait Spots; | 2015 |
Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.
Topics: Amnesia; Animals; Blood Glucose; Brain Diseases; Brain-Derived Neurotrophic Factor; Choline; Diabete | 2017 |
[A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
Topics: Adolescent; Adult; Brain Diseases; Brain Injuries; Cognition Disorders; Dipeptides; Humans; Middle A | 2008 |
Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
Topics: Adolescent; Adult; Brain Diseases; Brain Injuries; Cognition Disorders; Dipeptides; Humans; Middle A | 2009 |
[The results of using lucetam in patients with moderate cognitive impairment of different genesis].
Topics: Aged; Brain Diseases; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Foll | 2008 |
Nocturnal frontal lobe epilepsy presenting with restless leg syndrome-like symptoms.
Topics: Anticonvulsants; Brain Diseases; Carbamazepine; Electroencephalography; Epilepsy; Epilepsy, Frontal | 2011 |
Cortical laminar necrosis related to prolonged focal status epilepticus.
Topics: Adult; Anticonvulsants; Aphasia, Wernicke; Brain Diseases; Cerebral Cortex; Functional Laterality; H | 2006 |
Atypical case of Aicardi-Goutières syndrome with late-onset myoclonic status.
Topics: Adult; Basal Ganglia Diseases; Brain Diseases; Calcinosis; Comorbidity; Epilepsies, Myoclonic; Epile | 2007 |
Levetiracetam use in critically ill patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Diseases; Brain Ne | 2007 |
Encephalopathy induced by levetiracetam added to valproate.
Topics: Adult; Anticonvulsants; Brain Diseases; Electroencephalography; Epilepsy; Humans; Levetiracetam; Mal | 2008 |
An adverse reaction to piracetam in an hypothyroid 10 year old boy.
Topics: Brain Diseases; Child; Double-Blind Method; Humans; Hypothyroidism; Learning Disabilities; Male; Pir | 1980 |
[Myoclonus of focal action and localized hemispheric lesion. A polygraphic and pharmacological study].
Topics: Anticonvulsants; Brain Diseases; Brain Ischemia; Cerebral Cortex; Clonazepam; Electroencephalography | 1995 |
Usefulness of piracetam in intensive care.
Topics: Alcoholism; Brain Diseases; Brain Injuries; Carbon Monoxide Poisoning; Cerebrovascular Disorders; Ch | 1976 |
[Various rarely encountered adverse effects and complications of psychopharmacotherapy].
Topics: Adult; Agnosia; Amitriptyline; Apraxias; Brain Diseases; Cerebral Cortex; Haloperidol; Humans; Male; | 1985 |
[Geriatric patient in the general practice].
Topics: Adult; Age Factors; Aged; Brain Diseases; Energy Transfer; Family Practice; Female; Humans; Male; Mi | 1974 |